Evonik’s non-animal-derived squalene PhytoSquene is now available produced under GMP. Launched last year, PhytoSquene, is the first GMP amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms, according to the company. By offering plant-based squalene, Evonik is meeting the demand for a secure commercial supply of squalene for pharmaceutical applications, which is currently refined from shark liver oil.    PhytoSquene is made from the oil of amaranth (Amaran...